Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Drug Discovery Today|July 23, 2011
Target-drug interactions: first principles and their application to drug discoverySara Núñez, Jennifer Venhorst, Chris G KruseChemical Record (New York, N.Y.)|June 20, 2008
Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectivesJos H M Lange, Chris G KruseCurrent Opinion in Drug Discovery & Development|September 2, 2004
Recent advances in CB1 cannabinoid receptor antagonistsJos H M Lange, Chris G KruseJournal of Chemical Information and Modeling|April 2, 2010
Assessment of a novel scoring method based on solvent accessible surface area descriptorsSara Núñez, Jennifer Venhorst, Chris G KruseDrug Discovery Today|May 18, 2005
Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonistsJos H M Lange, Chris G KruseACS Medicinal Chemistry Letters|June 6, 2014
Design of a high fragment efficiency library by molecular graph theoryJennifer Venhorst, Sara Núñez, Chris G KruseChemmedchem|July 31, 2008
Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptorsAntoni R Blaazer, Pieter Smid, Chris G KruseCurrent Pharmaceutical Design|June 6, 2015
5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in SchizophreniaNatasja M W J de Bruin, Chris G KruseJournal of Medicinal Chemistry|May 2, 2008
Assessment of scaffold hopping efficiency by use of molecular interaction fingerprintsJennifer Venhorst, Sara Núñez, Jan Willem Terpstra, et al.Synapse (New York, N.Y.)|January 11, 2011
NK3 receptors mediate an increase in firing rate of midbrain dopamine neurons of the rat and the guinea pigTaco R Werkman, Andrew C McCreary, Chris G Kruse, et al.Pageof 5